Discover investment opportunities in Robotic Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Robotic Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Robotic Stocks using our Smart AI Filter.
8 stocks found for "Robotic Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.64 Risk measure | ±28.2% Price volatility | 69.3 Valuation | 0.00% Annual yield | |||
2.43 Risk measure | ±100.0% Price volatility | -2.2 Valuation | 0.00% Annual yield | |||
1.17 Risk measure | ±48.9% Price volatility | 21.9 Valuation | 0.53% Annual yield | |||
0.45 Risk measure | ±34.4% Price volatility | 36.3 Valuation | 0.00% Annual yield | |||
0.65 Risk measure | ±24.2% Price volatility | 8.6 Valuation | 3.75% Annual yield | |||
0.64 Risk measure | ±29.8% Price volatility | 26.5 Valuation | 0.00% Annual yield | |||
1.02 Risk measure | ±32.8% Price volatility | 30.4 Valuation | 1.53% Annual yield | |||
0.85 Risk measure | ±32.1% Price volatility | 20.2 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What competitive advantages do companies like ISRG and IRBT offer in the healthcare sector?
A: ISRG's da Vinci surgical system provides minimally invasive surgical options, with a strong market position in robotic surgery. IRBT focuses on robotic vacuums, leveraging advanced AI. Both benefit from technological innovation and patents, creating high entry barriers for competitors.
Q: How do FANUY and ABB compare in terms of exposure to industrial automation?
A: FANUY and ABB are leaders in industrial automation, serving various sectors worldwide. FANUY excels in robotics for manufacturing, while ABB is prominent in both robotics and electrical equipment. Their global reach and comprehensive solutions offer strong competitive positions.
Q: Is there potential for dividend income from stocks like ABB or ROK?
A: ABB and ROK both offer dividends, with ABB often having higher yields. Dividend stability varies; investors should consider payout ratios and historical performance to assess long-term sustainability of dividends.
Q: What are the common risks associated with investing in robotic stocks like AVAV and CGNX?
A: Risks include rapid technological changes, high R&D costs, and competitive pressures. AVAV, with a focus on drones, faces regulatory scrutiny, while CGNX's machine vision systems must adapt to evolving industrial needs.
Q: How have defense-related robotics stocks like NOC performed historically in economic downturns?
A: Historically, NOC, a key defense contractor, shows resilience during downturns due to stable government contracts. Their financial performance may be less affected by economic cycles compared to consumer-focused tech companies.
Q: What are the growth prospects for medical robotics compared to other sectors?
A: Medical robotics, driven by ISRG, benefits from increasing demand for less invasive surgeries and an aging population. Growth prospects are robust compared to traditional sectors, driven by technological advances and healthcare needs.
Besides Wall Street's top-and-bottom-line estimates for Intuitive Surgical (ISRG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Read more